Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab - EADV | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
EADV
2017
·
Europe
·
Dermatology
Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab
Document
Analyser ce document
